Browsing by Author "Yüksel, Esma İnan"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Publication Social media use in patients with acne vulgaris: What do patients expect from social media?(Wiley, 2021-06-01) Kayıran, Melek Aslan; Karadağ, Ayşe Serap; Alyamaç, Gökçen; Cemil, Bengü Çevirgen; Demirseren, Düriye Deniz; Aksoy, Hasan; Kılıç, Sevilay Oğuz; Demircan, Yuhanize Taş; Yüksel, Esma İnan; Kalkan, Göknur; Yaşar, Gülbin; Aktürk, Aysun Sıkar; Kutlu, Ömer; Kaksi, Sümeyye Altıntaş; Aksaç, Sema Elibüyük; Erdoğan, Hilal Kaya; Özden, Hatice Kaya; Solak, Sezgi Sarıkaya; Koska, Mahmut Can; Yazıcı, Serkan; YAZİCİ, SERKAN; Bursa Uludağ Üniversitesi/Tıp Fakültesi/Deri ve Zührevi Hastalıklar Anabilim Dalı.; AAH-2459-2021Background Acne vulgaris (AV) may affect external appearance and significantly deteriorate the quality of life of patients. Therefore, patients make various inquiries about their disease and seek treatment options.Aims To investigate the social media usage habits of patients with AV concerning their diseases, and their recommendations for dermatologists related to social media use.Methods A total of 1609 patients with AV completed the survey prepared by the authors and the Cardiff Acne Disability Index questionnaire. The Food and Drug Administration severity scores and clinical information of the patients were noted by their physicians.Results Of the 1,489 patients who stated that they used social media, 46.31% regularly and 28.77% sometimes referred to these sources to make inquiries about AV. Social media usage for AV was statistically significantly higher in women, participants with short term and severe disease, those with a moderate income level, and those using topical treatment and cosmetics. They mostly used Google (67%), Instagram (54%), and YouTube (49%). While 76% of the participants stated that they did not share what they saw on the Internet with their doctor. Of the respondents, 18.5% were trying to contact their dermatologists through the Internet, and 69.73% would prefer experts such as dermatologists to post-AV-related content.Conclusions Our study shows that patients frequently resort to social media to seek information about AV. In the changing digital world order, it is observed that there is a need for dermatologists to use social media more actively to share accurate information about AV.Publication The impact of Covid-19 pandemic on psoriasis patients, and their immunosuppressive treatment: A cross-sectional multicenter study from Turkey(Taylor & Francis, 2021-05-05) Kartal, Selda Pelin; Çelik, Gökçen; Yılmaz, Oğuz; Öksüm Solak, Eda; Demirbağ Gül, Büşra; Üstünbaş, Tuba Kevser; Gönülal, Melis; Baysak, Sevim; Yüksel, Esma İnan; Ünlü, Begüm; Güven, Münevver; Bozdağ, Ali; Çınar, Gökhan; Kartal, Selim; Borlu, Murat; Özden, Müge Güler; Engin, Burhan; Serdaroğlu, Server; Balcı, Didem Didar; Doğan, Bilal; Çiçek, Demet; Yazıcı, Ayça Cordan; Aytekin, Sema; Şendur, Neslihan; Sarıcaoğlu, Hayriye; Kaçar, Nida Gelincik; Doğramacı, Asena Çiğdem; Dönmez, Levent; Alpsoy, Erkan; BOZDAĞ, ALİ; SARICAOĞLU, HAYRİYE; Bursa Uludağ Üniversitesi/Tıp Fakültesi/Dermatoloji Anabilim Dalı.; 0000-0001-6068-6348; DUW-2729-2022; DPU-8534-2022Background Immunosuppressive therapy has been a great concern during the pandemic. This study aimed to evaluate the pandemic's impact on psoriasis patients treated with immunosuppressive drugs. Material and Methods The multicenter study was conducted in 14 tertiary dermatology centers. Demographic data, treatment status, disease course, and cases of COVID-19 were evaluated in patients with psoriasis using the immunosuppressive treatment. Results Of 1827 patients included, the drug adherence rate was 68.2%. Those receiving anti-interleukin (anti-IL) drugs were more likely to continue treatment than patients receiving conventional drugs (OR = 1.50, 95% CI, 1.181-1.895, p = .001). Disease worsening rate was 24.2% and drug dose reduction increased this rate 3.26 and drug withdrawal 8.71 times. Receiving anti-TNF or anti-IL drugs was associated with less disease worsening compared to conventional drugs (p = .038, p = .032; respectively). Drug withdrawal causes were 'unable to come' (39.6%), 'COVID concern' (25.3%), and 'physician's and patient's co-decision' (17.4%). Four patients had COVID-19 infection with mild symptoms. The incidence was 0.0022% while it was 0.0025% in the general population. Conclusion Our study shows that psoriasis patients using systemic immunosuppressive do not have a higher, but even lower COVID-19 risk than the general population, and treatment compliance with biological drugs is higher.